ClinicalTrials.Veeva

Menu

Presbyopic Phakic Intraocular Lens for Myopia Correction

G

Gemini Eye Clinic

Status

Completed

Conditions

Myopia
Presbyopia

Treatments

Device: Presbyopic posterior chamber phakic intraocular lens IPCL

Study type

Interventional

Funder types

Industry

Identifiers

NCT03836898
PhakicIOL Presbyopia

Details and patient eligibility

About

This is a prospective single-center study of implantations of the presbyopic version of phakic intraocular lens IPCL (EyeolUK, United Kingdom).

Full description

Participants are impanted with the phakic intraocular lens IPCL (EyeolUK, United Kingdom) and monitored during 2 years period. Visual acuity for near and distance is evaluated, along with refraction and endothelium cell density.

Enrollment

10 patients

Sex

All

Ages

38 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CDVA < 0.3 LogMAR
  • Presbyopia with moderate to high myopia
  • Phakic

Exclusion criteria

  • Corneal endotehleial cell density below 2000 cells/mm2
  • Corneal dystrophies
  • ACD less than 2.8 mm
  • history or current uveitis
  • acute ocular inflammation
  • glaucoma
  • chronic uveitis
  • previous intraocular or refractive surgery
  • preexisting ocular pathologic which may affect postoperative results

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Implantation phakic intraocular lens
Experimental group
Description:
Presbyopic posterior chamber phakic intraocular lens IPCL implanted to the participants eye
Treatment:
Device: Presbyopic posterior chamber phakic intraocular lens IPCL

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems